Bayer Aktiengesellschaft BAYRY
15.18 USD +0.77 (+5.34%)
Nov 4, 2026, 11:49 AM EST
14.97 Day range 15.19
7.57 52-week range 15.19
- YTD
- +40.30%
- 1 year
- +99.47%
- Market cap
- 59.65B
- EPS (ttm)
- -0.43
- YTD return
- +40.30%
- 1-year return
- +99.47%
- Volume
- 198.56K
- Avg volume
- 604.88K
- Open
- 15.05
- Previous close
- 14.41
- Day's range
- 14.97 – 15.19
- 52-week range
- 7.57 – 15.19
- Earnings date
- Nov 3, 2026
30m +1.95 (+14.84%)
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 0.13.
Financials — quick view
BAYRY Revenue — annual 28.96B
BAYRY Net income — annual 1.68B
BAYRY EPS — annual 2.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.13 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.23 | 0.29 | +0.06 | +26.09% |
| May 12, 2026 | Mar 31, 2026 | 0.64 | 0.79 | +0.15 | +23.44% |
| Mar 4, 2026 | Dec 31, 2025 | 0.18 | 0.18 | 0.00 | 0.00% |
| Nov 12, 2025 | Sep 30, 2025 | 0.13 | 0.17 | +0.04 | +30.77% |
| Aug 6, 2025 | Jun 30, 2025 | 0.25 | 0.35 | +0.10 | +40.00% |
News
Bayer and America's Grow-a-Row Continue Partnership to Fight Food Insecurity 
Bayer seeks bigger role in fast-growing Latin American biologicals market 
BAYRY Q3 Earnings and Revenues Miss Estimates, Pharma Performs Well 
Bayer to Present New Cardiovascular, Kidney and Stroke Data at the 2026 American Heart Association (AHA) Scientific Sessions 
Bayer AG: Solid Q3 Earnings, But Still A 'Prove-It' Story 
Bayer Aktiengesellschaft (BAYRY) Q3 2026 Earnings Call Transcript 
What Bayer Aktiengesellschaft (BAYN) Said on Its Q3 Earnings Call 
Bayer Raises Earnings Outlook on Pharma Recovery 
Bayer raises 2026 profit outlook 
Bayer Gets in China Its First Global Approval for Stroke Prevention Drug
Your note
Sign in to keep a note on BAYRY — it syncs with the Stock Master app.